Related Articles
Prognostic value of estrogen receptor status can be improved by combined evaluation of p53, Bcl2 and PgR expression: an immunohistochemical study on breast carcinoma with long-term follow-up.
Immunohistochemical assessment of primary breast tumors and metachronous brain metastases, with particular regard to differences in the expression of biological markers and prognosis
Predictive significance of the proportion of ER-positive or PgR-positive tumor cells in response to neoadjuvant chemotherapy for operable HER2-negative breast cancer
P(185/HER2) AND PS2 PROTEIN OVEREXPRESSION IN BREAST-CANCER SPECIMENS - IMPROVEMENT FOR PREDICTION OF RESPONSE TO ENDOCRINE THERAPY
BIOLOGICAL AND CLINICAL RELEVANCE OF PROLIFERATIVE ACTIVITY IN INFLAMMATORY BREAST-CANCER